ALZAMEND NEURO INC (ALZN) Stock Cash Flow
NASDAQ:ALZN - Nasdaq - US02262M5067 - Common Stock - Currency: USD
| TTM (2025-1-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -4.23M | -9.95M | -14.88M | -12.36M | -5.05M | |||
| Depreciation Amortization | 50.70K | 50.70K | 20.00K | 0.00 | N/A | |||
| Change In Working Capital | -3.46M | 670.70K | 2.35M | 1.33M | -150.00K | |||
| Other non cash items | 335.10K | 956.40K | 3.58M | 4.42M | 2.49M | |||
| OPERATING CASH FLOW | -7.31M | -8.27M | -8.92M | -6.61M | -2.71M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -90.00K | -147.20K | 0.00 | -110.00K | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 100.00K | |||
| INVESTING CASH FLOW | -90.00K | -147.20K | 0.00 | -110.00K | 100.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 300.00K | N/A | 0.00 | 400.00K | |||
| Stock Issued/Repurchased | 10.17M | 3.35M | 0.00 | 18.91M | 2.10M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -60.00K | 1.95M | |||
| FINANCING CASH FLOW | 10.47M | 3.65M | 0.00 | 18.85M | 4.45M | |||
| CHANGE IN CASH | 3.08M | -4.76M | -8.92M | 12.13M | 1.84M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.31M | -8.27M | -8.92M | -6.61M | -2.71M | |||
| Capital Expenditure | -90.00K | -147.20K | 0.00 | -110.00K | N/A | |||
| FREE CASH FLOW | -7.40M | -8.42M | -8.92M | -6.72M | -2.71M | |||
All data in USD